FLAGSTAFF, Ariz.--(BUSINESS WIRE)--July 27, 2006--W. L. Gore & Associates (Gore) announced today that site initiation and enrollment has begun in the EMPiRE (Embolic Protection with flow Reversal) Clinical Study. This investigational clinical study is designed to demonstrate the safety and efficacy of the GORE Neuro Protection System when used for embolic protection during carotid artery stenting procedures. The first patients were enrolled and successfully treated for narrowing of the carotid arteries at the University of Buffalo. The patients all recovered from their procedure without incident, and have been discharged from the hospital.
